MARKET

PODD

PODD

Insulet Corp
NASDAQ
292.21
+0.70
+0.24%
Opening 11:00 12/16 EST
OPEN
296.36
PREV CLOSE
291.51
HIGH
296.36
LOW
291.90
VOLUME
136.84K
TURNOVER
--
52 WEEK HIGH
354.88
52 WEEK LOW
230.05
MARKET CAP
20.56B
P/E (TTM)
84.78
1D
5D
1M
3M
1Y
5Y
1D
Insulet Price Target Announced at $370.00/Share by Evercore ISI Group
Dow Jones · 9h ago
Evercore ISI Group Initiates Coverage On Insulet with Outperform Rating, Announces Price Target of $370
Benzinga · 10h ago
Insulet initiated with an Outperform at Evercore ISI
TipRanks · 10h ago
Is Phibro Animal Health Stock a Smart Addition to Your Portfolio Now?
NASDAQ · 11h ago
TMO Stock Set to Gain From the Expansion of Gibco Bacto Portfolio
NASDAQ · 11h ago
BUZZ-U.S. STOCKS ON THE MOVE-premarket
Reuters · 11h ago
Insulet Corporation to Present at J.P. Morgan Healthcare Conference
Reuters · 11h ago
BUZZ-Insulet gets 'outperform' rating as Evercore starts coverage
Reuters · 12h ago
More
About PODD
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Webull offers Insulet Corp stock information, including NASDAQ: PODD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PODD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PODD stock methods without spending real money on the virtual paper trading platform.